Jazz Pharmaceuticals
JAZZ
#1428
Rank
NZ$27.69 B
Marketcap
NZ$431.43
Share price
3.10%
Change (1 day)
82.26%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): NZ-$2.17

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$27.18. In 2022 the company made an earnings per share (EPS) of NZ-$6.31 an increase over its 2021 EPS that were of NZ-$9.59.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$2.17-65.63%
2022NZ-$6.31-34.2%
2021NZ-$9.59-224.83%
2020NZ$7.68-53.25%
2019NZ$16.4323.59%
2018NZ$13.30-8.24%
2017NZ$14.4923.74%
2016NZ$11.7122.12%
2015NZ$9.59478.49%
2014NZ$1.66-74.93%
2013NZ$6.61-27.11%
2012NZ$9.0769.1%
2011NZ$5.37245.98%
2010NZ$1.55-462.5%
2009NZ-$0.43-96.7%
2008NZ-$12.98-27.04%
2007NZ-$17.7965.47%
2006NZ-$10.75-4.59%
2005NZ-$11.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.36-65.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
NZ$14.78-45.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
NZ-$1.91-107.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
NZ$1.12-95.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel